SCHEMBL1809879

SCHEMBL1809879

CCc1cc(F)c(-c2[nH]nc(C)c2C(=O)O)c(C#N)c1

nearest known ligand 0.34

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
XDH P47989 2/20 0.34
KDM4E B2RXH2 3/20 0.33
ALDH1A1 P00352 2/20 0.33
HSD17B10 Q99714 2/20 0.33
PDE4D Q08499 1/20 0.33
HPGD P15428 1/20 0.32
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
LRRK2 Q5S007 1/20 0.31
HTT P42858 1/20 0.31
CA12 O43570 1/20 0.31
ALPL P05186 1/20 0.31
CA9 Q16790 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
GAA P10253 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
HCAR2 Q8TDS4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1806510 0.83 PDE4D (0.35) PDE4DCA12ALPLCA9HCAR2
SCHEMBL1805098 0.81 PDE4D (0.33) PDE4DCA12ALPLCA9HCAR2
SCHEMBL1807105 0.80 PRKCE (0.39) ALDH1A1HSD17B10PDE4DCA12ALPL
SCHEMBL1804792 0.80 PARP1 (0.34) ALDH1A1HSD17B10PDE4DCA12ALPL
SCHEMBL1805134 0.75 PDE4D (0.34) PDE4D
SCHEMBL1803881 0.69 HTR2A (0.34) ALDH1A1
SCHEMBL1806149 0.66 HCAR2 (0.42) CA12ALPLCA9HCAR2
SCHEMBL12181094 0.66 RXRA (0.44) ALDH1A1CA12ALPLCA9GAA
SCHEMBL23699454 0.65 RXRA (0.36) XDHKDM4EALDH1A1HSD17B10HPGD
SCHEMBL27685454 0.64 PTGS1 (0.40) KDM4EALDH1A1HSD17B10HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2501704-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS Eli Lilly and Company (US) 2012-09-26 EP disclosed
WO-2011060217-A1 SPIROPIPERIDINE COMPOUNDS AS ORL-1 RECEPTOR ANTAGONISTS ELI LILLY AND COMPANY (US) 2011-05-19 WO disclosed